| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8957049 | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2018 | 4 Pages |
Abstract
There were significant reductions in HbA1c and statistically insignificant weight gain over 12 months. Switching from GLP-1 analogues to Xultophy was associated with a greater HbA1c reduction compared to switching from insulin.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David M. Williams, Natasha Shrikrishnapalasuriyar, Waheeba Syed, Win L. Yin, Richard Chudleigh, Stephen C. Bain, David E. Price, Jeffrey W. Stephens,